These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 458736)
41. [The clinical pharmacology of drugs for the therapy of the broncho-obstructive syndrome]. Zaĭtsev AA; Karpov OI Farmakol Toksikol; 1990; 53(3):80-3. PubMed ID: 2201567 [TBL] [Abstract][Full Text] [Related]
42. [Clinical pharmacology in the domain of pulmonology]. Renovanz HD Int Z Klin Pharmakol Ther Toxikol; 1970 Oct; 3(4):383-409. PubMed ID: 4394808 [No Abstract] [Full Text] [Related]
43. [Clinical pharmacology in the domain of pulmonology]. Renovanz HD Int Z Klin Pharmakol Ther Toxikol; 1970 Oct; 4(4):383-409. PubMed ID: 4395490 [No Abstract] [Full Text] [Related]
44. Treatment of chronic bronchial asthma in the adult. Banov CH J S C Med Assoc; 1973 Nov; 69(11):426-31. PubMed ID: 4584260 [No Abstract] [Full Text] [Related]
45. [Intermittent prevention and therapy of chronic respiratory tract diseases]. Wolkerstorfer H Wien Med Wochenschr; 1969 Oct; 119(42):734-6. PubMed ID: 5362166 [No Abstract] [Full Text] [Related]
46. [Chronic obstructive syndrome in bronchopulmonary pathology in children]. Bîscă N; Sibila S; Duţu St Rev Pediatr Obstet Ginecol Pediatr; 1976; 25(4):297-309. PubMed ID: 828760 [No Abstract] [Full Text] [Related]
47. Treatment of bronchial asthma in children. Lipschutz A Ann Allergy; 1967 Jan; 25(1):42-6. PubMed ID: 6016741 [No Abstract] [Full Text] [Related]
49. [Evaluation of the bronchospasmolytic activity of alupent and ipradol]. Makel'skiĭ VV; Iartsev SS Sov Med; 1974 Sep; 0(9):142-3. PubMed ID: 4409508 [No Abstract] [Full Text] [Related]
50. [External respiratory function in combined therapy of chronic nonspecific lung diseases and the bronchospasm syndrome]. Usenko IuD; Babich GG; Petrova IE; Filippova ES Vrach Delo; 1981 May; (5):19-21. PubMed ID: 6789554 [No Abstract] [Full Text] [Related]
51. [Therapy of the acute bronchospasm in the OR?]. Wagner K; Schell J; Schmucker P Anaesthesist; 1998 Dec; 47(12):1004-5. PubMed ID: 9893897 [No Abstract] [Full Text] [Related]
52. [Anticholinergic agents as bronchodilator agents. Significance of acetylcholine as a bronchoconstrictor transmitter agent in airway obstruction]. Ulmer WT; Dorsch J; Iravani J; Schüler KG; Stempel G; Vastag E Arzneimittelforschung; 1973 Mar; 23(3):468-76. PubMed ID: 4740138 [No Abstract] [Full Text] [Related]
53. [Asthmopent in the diagnosis and treatment of bronchial spasm in patients with pulmonary tuberculosis]. Dominchen MN Vrach Delo; 1974 Aug; 0(8):107-10. PubMed ID: 4408619 [No Abstract] [Full Text] [Related]
54. [Bronchodilator effect of fenoterol. Duration of activity and use in the basic treatment of bronchospasm]. Dierckx JP; Gillard C; Gossart R Brux Med; 1974 May; 54(5):297-301. PubMed ID: 4429838 [No Abstract] [Full Text] [Related]
55. [Treatment of bronchial spasm with anticholinergic agents]. Vastag E; Nagy L Orv Hetil; 1974 Oct; 115(41):2432-5. PubMed ID: 4418053 [No Abstract] [Full Text] [Related]
56. [Clinical study of Bisolvonamide in the treatment of the bronchitic syndrome]. Winterberg H; Wieser O; Darai G Ther Ggw; 1970 Jun; 109(6):885-6 passim. PubMed ID: 5453887 [No Abstract] [Full Text] [Related]
58. [Results obtained with bronchodilator aerosol of 1-(3,5 dehydroxyphenyl)-2-isopropylaminoethanol sulphate]. Ruiz Benítez G Rev Clin Esp; 1966 Aug; 102(4):305-10. PubMed ID: 5995634 [No Abstract] [Full Text] [Related]
59. [New developments in the field of bronchospasmolytics]. Nolte D Clin Ter; 1980 Jan; 92(1):3-13. PubMed ID: 7449306 [No Abstract] [Full Text] [Related]
60. [Mechanism of action and indications for administration of some bronchodilator agents]. Nikodýmová L; Růzicka J Cas Lek Cesk; 1971 Oct; 110(41):945-50. PubMed ID: 5112128 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]